medigraphic.com
ISSN 1817-5996 (Electronic)

2020, Number S1

<< Back Next >>

Rev Cub de Reu 2020; 22 (S1)

Monoclonal gammopathies with clinical significance in rheumatology

Reibaldi AA, Sager L, Calvo R, Ortiz A, Roverano S, Paira S

Language: Spanish
References: 22
Page:
PDF size: 661.03 Kb.


ABSTRACT

Monoclonal gammapathies are a broad group of diseases from hematopoietic cells with variable clinical features and systemic or limited involvement. These entities could begin as a rheumatic disease, even previously to the diagnosis of MG. To describe five patients with rheumatic manifestations that lately were diagnosed as monoclonal gammapathies. We describe the more relevant features of five patients assisted in our rheumatology center. Four patients were diagnosed with multiple myeloma that begins as: 1) Schnitzler’s syndrome, 2) Adult-onset xanthogranuloma and amyloidosis, 3) multiple vertebral fracture, 4) acute kidney failure. The 5th patient has a vasculitis-like syndrome due to an intravascular lymphoma. The rheumatic-like syndromes are infrequent but we should take into account this diagnosis in our clinical practice for rapid diagnostic and correct treatment.


REFERENCES

  1. Lipsker D. Monoclonal gammopathy of cutaneous significance: Review of relevant concept. Review article. JEADV. 2016. Doi: https://doi.org/10.1111/jdv.13847

  2. Mnshi N, Longo D, Anderson K. Trastornos de células plasmáticas. En: Longo DL, et al. eds. Harrison Principios de Medicina Interna. Décimo octava ed. New York: McGrawHill; 2012. p. 936-44.

  3. Schnitzler L: Lésions urticariennes chroniques permanentes (¿érythème pétaloïde?) Cas cliniques, n° 46 B. J Dermatologique d'Angers. 1972.

  4. Schnitzler L, Schubert B, Boasson M, Gardais J, Tourmen A. Urticaire chronique, lésions osseuses, macroglobulinémie IgM: maladie de Waldenström? 2ème présentation. Bull Soc Fr Dermatol Syphil. 1974;81:363.

  5. Lipsker D. The Schnitzler Syndrome. OJRD. 2010;5:38. Doi: https://doi.org/10.1186/1750-1172-5-38

  6. de Koning HD, Bodar EJ, van der Meer JW, Simon A, Schnitzler Syndrome Study Group. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum. 2007;37(3):137-48.

  7. Finucci Curi P. Síndrome de Schnitzler tratado con canakinumab. Rev SAR. 2019;30(3):34-7.

  8. Gallo J, Paira S. Síndrome de Schnitzler. Cartas al Editor. Reumatol Clin. 2015;11(2):123-30.

  9. Baykal C, Ekinci A, Kurtulos D. Review: The clinical spectrum of xanthomatous lesions of the eyelids. IJD. 2017;1-12. Doi: https://doi.org/10.1111/ijd.13637

  10. Daoud M, Lust J, Kyle R. Monoclonal gammopathies and associated skin disorders. AAD. 1999 [Acceso 20/07/2019];40(4):507-35. Disponible en: https://www.jaad.org/article/S0190-9622(99)70434-2/fulltext

  11. Miguel D, Lukacs J, Illing T, Elsner P. Treatment of necrobiotic xanthogranuloma a systematic review. JEADV. 2017;31:221-35. Doi: https://doi.org/10.1111/jdv.13786

  12. Wettle C, Springinsfeld G, Lipsker D. Cutaneous haemorrhage induced by minimal trauma as a sign of light chain-associated amyloidosis. BJH. 2012 159:383. Doi: https://doi.org/10.1111/bjh.12050

  13. Baixauli R, Garcia N, Hernandez O, Calvo C, Campos Fernandez C. Aplastamiento vertebral no osteoporótico. REEMO. 2004 [Acceso 20/08/2019];13(1):21-3. Disponible en: https://www.elsevier.es/es-revista-reemo-70-articulo-aplastamiento-vertebral-no-osteoporotico-13060566

  14. Contte M, Isnardi S, Sieza Y. Enfermedad ósea en el mieloma múltiple. SAH. 2010 [Acceso 20/08/2019];14(2):29-40. Disponible en: http://www.sah.org.ar/Revista/numeros/vol14.n2.29-40.pdf

  15. Fiore N, Romano O, Cedola J, Lambre J. Diagnóstico diferencial en aplastamientos vertebrales. Rev Asoc Arg Ortop y Traumatol. 2001 [Acceso 20/08/2019];67(1):6-15. Disponible en: https://www.aaot.org.ar/revista/1993_2002/2002/2002_1/670101.pdf

  16. Leucouvet F, Vande Berg B, Maldague B. Vertebral compression fractures in Multiple Myeloma. Distribution and appearance at MR imaging. Radiology. 1997 [Acceso 20/08/2019];204:195-9.

  17. Edwards CM, Zhuang J, Mundy GR. The pathogenesis of the bone disease of multiple myeloma. Bone. 2008 [Acceso 20/08/2019];42:1007-13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474770/

  18. Smith A, Wisloff F, Samsom D. Guidelines on the diagnosis and management of multiple myeloma. BJH. 2005;132:410-51. Doi: https://doi.org/10.1111/j.1365-2141.2005.05867.x

  19. Garcia Muñoz R, Mediavilla S, Robles de Castro D. Intravascular large B cell lymphoma. Leukemia Research Reports Elsevier. 2014;3:21-3. Doi: https://dx.doi.org/10.1016%2Fj.lrr.2013.12.002

  20. Parera MJ, Peresin Paz RM, Sutovsky DJ. Linfoma intravascular a células B grandes. SAH. 2014 [Acceso 20/08/2019];18(3):287-91. Disponible en: http://www.sah.org.ar/revista/numeros/vol.18n.3.287.291.pdf

  21. Manciola F, Stemberg E. Mieloma múltiple e injuria renal. Hematologia. 2013 [Acceso 20/08/2019];17(3):256-65. Disponible en: http://www.sah.org.ar/revista/numeros/Vol17n3-Mieloma%20Multiple%20e%20injuria.pdf

  22. Lee CK, Zangari M, Barlogia B. Dialysis dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant. BMT. 2004 [Acceso 20/08/2019];33:823-8. Disponible en: http://www.nature.com/articles/1704440.pdf




2020     |     www.medigraphic.com